What is a known risk associated with using SAMe during lactation?

During lactation, the safety of various supplements and medications is crucial to consider due to the potential effects on breastmilk and, consequently, the infant. SAMe, or S-adenosylmethionine, is known for its role in mood regulation and potential benefits for various conditions; however, research on its safety during breastfeeding is limited.

The choice to avoid SAMe is based on the lack of conclusive evidence regarding its safety in lactating mothers. While some may argue mild side effects could occur, these are not firmly established, and recommendations can vary widely among health professionals. SAMe is not universally recommended for all breastfeeding mothers due to these uncertainties, as it may result in unintentional exposure to the infant.

Thus, the known risk associated with using SAMe during lactation is primarily its uncertain safety profile, which leads to the advised caution and avoidance in breastfeeding mothers.